Progress in clinical genetics of prostate cancer by Cybulski C, Wokołorczyk D

Get full text

Neoadjuvant chemotherapy with Cisplatin in BRCA1 mutation carriers – results of treatment by Byrski T, Gronwald J, Huzarski T, Marczyk E, Blecharz P, Ashuryk O, Cybulski C, Zuziak D, Wiśniowski R, Godlewski D, Narod SA, Lubiński J

Get full text

Why choose the treatment with cisplatin for BRCA1 breast cancers patients? by Byrski T, Huzarski T, Marczyk E, Blecharz P, Gronwald J, Ashuryk O, Cybulski C, Dębniak T, Zuziak D, Godlewski D, Kladny J, Lubinski J, Narod SA

Get full text

Neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients by Byrski T, Gronwald J, Huzarski T, Dent RA, Zuziak D, Wiśniowski R, Marczyk E, Blecharz P, Szurek O, Cybulski C, Dębniak T, Górski B, Lubiński J, Narod S

Get full text

Screening with Magnetic Resonance Imaging in women at low and intermediate risk of breast Cancer by Huzarski T T, Górecka-Szyld B, Huzarska J J, Psut G, Wilk G, Sibilski R, Cybulski C, Kozak-Klonowska B, Siołek M, Kilar E, Czudowska D, Janiszewska H, Godlewski D, Mackiewicz A, Jarkiewicz-Tretyn J, Szabo-Moskal I, Gronwald J, Lubiński J, Narod SA

Get full text

Impact of BRCA1 mutation on survival after early onset breast cancer by Huzarski T, Byrski T, Gronwald J, Górski B, Domagała W, Cybulski C, Sun Ping, Oszurek O, Szwiec M, Gugała K, Stawicka M, Morawiec Z, Mierzwa T, Janiszewska H, Kilar E, Marczyk E, Kozak-Klonowska B, Siołek M, Surdyka D, Wiśniowski R, Posmyk M, Lubiński J, Narod SA

Get full text

Cluster effect for SNP–SNP interaction pairs for predicting complex traits by Lin, H, Mazumder, H, Sarkar, I, Huang, P, Eeles, RA, Kote-Jarai, Z, Muir, KR, Schleutker, J, Pashayan, N, Batra, J, Neal, DE, Nielsen, SF, Nordestgaard, BG, Grönberg, H, Wiklund, F, MacInnis, RJ, Haiman, CA, Travis, RC, Stanford, JL, Kibel, AS, Cybulski, C, Khaw, K, Maier, C, Thibodeau, SN

Alcohol consumption and prostate cancer incidence and progression: A Mendelian randomisation study. by Brunner, C, Davies, NM, Martin, RM, Eeles, R, Easton, D, Kote-Jarai, Z, Olama, AA, Benlloch, S, Muir, K, Giles, G, Wiklund, F, Gronberg, H, Haiman, CA, Schleutker, J, Nordestgaard, BG, Travis, RC, Neal, D, Donovan, J, Hamdy, FC, Pashayan, N, Khaw, KT, Stanford, JL, Blot, WJ, Thibodeau, S, Maier, C, Kibel, AS, Cybulski, C, Cannon-Albright, L, Brenner, H, Park, J, Kaneva, R, Batra, J, Teixeira, MR, Pandha, H, Zuccolo, L

Assessing the role of insulin-like growth factors and binding proteins in prostate cancer using Mendelian randomization: Genetic variants as instruments for circulating levels by Bonilla, C, Lewis, S, Rowlands, M, Gaunt, T, Davey Smith, G, Gunnell, D, Palmer, T, Donovan, J, Hamdy, F, Neal, D, Eeles, R, Easton, D, Kote-Jarai, Z, Al Olama, A, Benlloch, S, Muir, K, Giles, G, Wiklund, F, Grönberg, H, Haiman, C, Schleutker, J, Nordestgaard, B, Travis, R, Pashayan, N, Khaw, K, Stanford, J, Blot, W, Thibodeau, S, Maier, C, Kibel, A, Cybulski, C, Cannon-Albright, L, Brenner, H, Park, J, Kaneva, R, Batra, J, Teixeira, M, Pandha, H, Lathrop, M, Martin, R, Holly, J

Polygenic hazard score is associated with prostate cancer in multi-ethnic populations by Huynh-Le, M, Fan, CC, Karunamuni, R, Thompson, WK, Martinez, ME, Eeles, RA, Kote-Jarai, Z, Muir, K, Schleutker, J, Pashayan, N, Batra, J, Grönberg, H, Neal, DE, Donovan, JL, Hamdy, FC, Martin, RM, Nielsen, SF, Nordestgaard, BG, Wiklund, F, Tangen, CM, Giles, GG, Wolk, A, Albanes, D, Travis, RC, Blot, WJ, Zheng, W, Sanderson, M, Stanford, JL, Mucci, LA, West, CML, Kibel, AS, Cussenot, O, Berndt, SI, Koutros, S, Sørensen, KD, Cybulski, C, Grindedal, EM, Menegaux, F, Khaw, K, Park, JY, Ingles, SA, Maier, C, Hamilton, RJ, Thibodeau, SN, Rosenstein, BS, Lu, Y, Watya, S, Watya, S, Vega, A, Kogevinas, M, Penney, KL, Mills, IG

The CHEK2 variant C.349A>G is associated with prostate cancer risk and carriers share a common ancestor by Brandão, A, Paulo, P, Maia, S, Pinheiro, M, Peixoto, A, Cardoso, M, Silva, MP, Santos, C, Eeles, RA, Kote-Jarai, Z, Muir, K, Ukgpcs Collaborators, Schleutker, J, Wang, Y, Pashayan, N, Batra, J, Apcb BioResource, Grönberg, H, Neal, DE, Nordestgaard, BG, Tangen, CM, Southey, MC, Wolk, A, Albanes, D, Haiman, CA, Travis, RC, Stanford, JL, Mucci, LA, West, CML, Nielsen, SF, Kibel, AS, Cussenot, O, Berndt, SI, Koutros, S, Sørensen, KD, Cybulski, C, Grindedal, EM, Park, JY, Ingles, SA, Maier, C, Hamilton, RJ, Rosenstein, BS, Vega, A, The Impact Study Steering Committee And Collaborators, Kogevinas, M, Wiklund, F, Penney, KL, Brenner, H, John, EM, Kaneva, R

Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants by Wang, A, Shen, J, Rodriguez, AA, Saunders, EJ, Chen, F, Janivara, R, Darst, BF, Sheng, X, Xu, Y, Chou, AJ, Benlloch, S, Dadaev, T, Brook, MN, Plym, A, Sahimi, A, Hoffman, TJ, Takahashi, A, Matsuda, K, Momozawa, Y, Fujita, M, Laisk, T, Figuerêdo, J, Muir, K, Ito, S, Liu, X, Biobank Japan Project, Uchio, Y, Kubo, M, Kamatani, Y, Lophatananon, A, Wan, P, Andrews, C, Lori, A, Choudhury, PP, Schleutker, J, Tammela, TLJ, Sipeky, C, Auvinen, A, Giles, GG, Southey, MC, MacInnis, RJ, Cybulski, C, Wokolorczyk, D, Lubinski, J, Rentsch, CT, Cho, K, Mcmahon, BH, Neal, DE, Donovan, JL, Hamdy, FC, Travis, RC, Key, TJ, Hunter, DJ

Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts. by Seibert, TM, Fan, CC, Wang, Y, Zuber, V, Karunamuni, R, Parsons, JK, Eeles, RA, Easton, DF, Kote-Jarai, Z, Olama, AA, Garcia, SB, Muir, K, Grönberg, H, Wiklund, F, Aly, M, Schleutker, J, Sipeky, C, Tammela, TL, Nordestgaard, BG, Nielsen, SF, Weischer, M, Bisbjerg, R, Røder, MA, Iversen, P, Key, TJ, Travis, RC, Neal, DE, Donovan, JL, Hamdy, FC, Pharoah, P, Pashayan, N, Khaw, K-T, Maier, C, Vogel, W, Luedeke, M, Herkommer, K, Kibel, AS, Cybulski, C, Wokolorczyk, D, Kluzniak, W, Cannon-Albright, L, Brenner, H, Cuk, K, Saum, K-U, Park, JY, Sellers, TA, Slavov, C, Kaneva, R, Mitev, V, Batra, J, Clements, JA, Spurdle, A, Teixeira, MR, Paulo, P, Maia, S, Pandha, H, Michael, A, Kierzek, A, Karow, DS, Mills, IG, Andreassen, OA, Dale, AM

Fine-mapping the HOXB region detects common variants tagging a rare coding allele: evidence for synthetic association in prostate cancer by Saunders, E, Dadaev, T, Leongamornlert, D, Jugurnauth-Little, S, Tymrakiewicz, M, Wiklund, F, Al Olama, A, Benlloch, S, Neal, D, Hamdy, F, Donovan, J, Giles, G, Severi, G, Gronberg, H, Aly, M, Haiman, C, Schumacher, F, Henderson, B, Lindstrom, S, Kraft, P, Hunter, D, Gapstur, S, Chanock, S, Berndt, S, Albanes, D, Andriole, G, Schleutker, J, Weischer, M, Nordestgaard, BG, Canzian, F, Campa, D, Riboli, E, Key, T, Travis, R, Ingles, SA, John, E, Hayes, R, Pharoah, P, Khaw, K, Stanford, J, Ostrander, E, Signorello, L, Thibodeau, SN, Schaid, D, Maier, C, Kibel, A, Cybulski, C, Cannon-Albright, L, Brenner, H, Park, J, Kaneva, R, Batra, J, Clements, J, Teixeira, MR, Xu, J, Mikropoulos, C, Goh, C, Govindasami, K, Guy, M, Wilkinson, R, Sawyer, E, Morgan, A, Easton, D, Muir, K, Eeles, R, Kote-Jarai, Z

A genetic hazard score to personalize prostate cancer screening, applied to population data by Huynh-Le, M-P, Fan, CC, Karunamuni, R, Walsh, EI, Turner, EL, Lane, JA, Martin, RM, Neal, DE, Donovan, JL, Hamdy, FC, Parsons, JK, Eeles, RA, Easton, DF, Kote-Jarai, Z, Olama, AAA, Garcia, SB, Muir, K, Gronberg, H, Wiklund, F, Aly, M, Schleutker, J, Sipeky, C, Tammela, TLJ, Nordestgaard, BG, Key, TJ, Travis, RC, Pharoah, P, Pashayan, N, Khaw, K-T, Thibodeau, SN, McDonnell, SK, Schaid, DJ, Maier, C, Vogel, W, Luedeke, M, Herkommer, K, Kibel, AS, Cybulski, C, Wokolorczyk, D, Kluzniak, W, Cannon-Albright, L, Brenner, H, Schöttker, B, Holleczek, B, Park, JY, Sellers, TA, Lin, H-Y, Slavov, C, Kaneva, R, Mitev, V, Batra, J, Clements, JA, Spurdle, A, Teixeira, MR, Paulo, P, Maia, S, Pandha, H, Michael, A, Kierzek, A, Mills, IG, Andreassen, OA, Dale, AM, Seibert, TM

Germline variation at 8q24 and prostate cancer risk in men of European ancestry by Matejcic, M, Saunders, EJ, Dadaev, T, Brook, MN, Wang, K, Sheng, X, Olama, AAA, Schumacher, FR, Ingles, SA, Govindasami, K, Benlloch, S, Berndt, SI, Albanes, D, Koutros, S, Muir, K, Stevens, VL, Gapstur, SM, Tangen, CM, Batra, J, Clements, J, Gronberg, H, Pashayan, N, Schleutker, J, Wolk, A, West, C, Mucci, L, Kraft, P, Cancel-Tassin, G, Sorensen, KD, Maehle, L, Grindedal, EM, Strom, SS, Neal, DE, Hamdy, FC, Donovan, JL, Travis, RC, Hamilton, RJ, Rosenstein, B, Lu, Y-J, Giles, GG, Kibel, AS, Vega, A, Bensen, JT, Kogevinas, M, Penney, KL, Park, JY, Stanford, JL, Cybulski, C, Nordestgaard, BG, Brenner, H, Maier, C, Kim, J, Teixeira, MR, Neuhausen, SL, De Ruyck, K, Razack, A, Newcomb, LF, Lessel, D, Kaneva, R, Usmani, N, Claessens, F, Townsend, PA, Gago-Dominguez, M, Roobol, MJ, Menegaux, F, Khaw, K-T, Cannon-Albright, LA, Pandha, H, Thibodeau, SN, Schaid, DJ, Wiklund, F, Chanock, SJ, Easton, DF, Eeles, RA, Kote-Jarai, Z, Conti, DV, Haiman, CA

Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression. by Kote-Jarai, Z, Saunders, E, Leongamornlert, D, Tymrakiewicz, M, Dadaev, T, Jugurnauth-Little, S, Ross-Adams, H, Al Olama, A, Benlloch, S, Halim, S, Russell, R, Russel, R, Dunning, A, Luccarini, C, Dennis, J, Neal, D, Hamdy, F, Donovan, J, Muir, K, Giles, G, Severi, G, Wiklund, F, Gronberg, H, Haiman, C, Schumacher, F, Henderson, B, Le Marchand, L, Lindstrom, S, Kraft, P, Hunter, D, Gapstur, S, Chanock, S, Berndt, S, Albanes, D, Andriole, G, Schleutker, J, Weischer, M, Canzian, F, Riboli, E, Key, T, Travis, R, Campa, D, Ingles, SA, John, E, Hayes, R, Pharoah, P, Khaw, K, Stanford, J, Ostrander, E, Signorello, L, Thibodeau, SN, Schaid, D, Maier, C, Vogel, W, Kibel, A, Cybulski, C, Lubinski, J, Cannon-Albright, L, Brenner, H, Park, J, Kaneva, R, Batra, J, Spurdle, A, Clements, J, Teixeira, MR, Govindasami, K, Guy, M, Wilkinson, R, Sawyer, E, Morgan, A, Dicks, E, Baynes, C, Conroy, D, Bojesen, SE, Kaaks, R, Vincent, D, Bacot, F, Tessier, D, Easton, D, Eeles, R

Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation by Gusev, A, Shi, H, Kichaev, G, Pomerantz, M, Li, F, Long, HW, Ingles, SA, Kittles, RA, Strom, SS, Rybicki, BA, Nemesure, B, Isaacs, WB, Zheng, W, Pettaway, CA, Yeboah, ED, Tettey, Y, Biritwum, RB, Adjei, AA, Tay, E, Truelove, A, Niwa, S, Chokkalingam, AP, John, EM, Murphy, AB, Signorello, LB, Carpten, J, Leske, MC, Wu, SY, Hennis, AJ, Neslund-Dudas, C, Hsing, AW, Chu, L, Goodman, PJ, Klein, EA, Witte, JS, Casey, G, Kaggwa, S, Cook, MB, Stram, DO, Blot, WJ, Eeles, RA, Easton, D, Kote-Jarai, Z, Olama, AA, Benlloch, S, Muir, K, Giles, GG, Southey, MC, Fitzgerald, LM, Gronberg, H, Wiklund, F, Aly, M, Henderson, BE, Schleutker, J, Wahlfors, T, Tammela, TL, Nordestgaard, BG, Key, TJ, Travis, RC, Neal, DE, Donovan, JL, Hamdy, FC, Pharoah, P, Pashayan, N, Khaw, KT, Stanford, JL, Thibodeau, SN, McDonnell, SK, Schaid, DJ, Maier, C, Vogel, W, Luedeke, M, Herkommer, K, Kibel, AS, Cybulski, C, Wokolorczyk, D, Kluzniak, W, Cannon-Albright, L, Teerlink, C, Brenner, H, Dieffenbach, AK, Arndt, V, Park, JY, Sellers, TA, Lin, HY, Slavov, C, Kaneva, R, Mitev, V, Batra, J, Spurdle, A, Clements, JA, Teixeira, MR, Pandha, H, Michael, A, Paulo, P, Maia, S, Kierzek, A, Conti, DV, Albanes, D, Berg, C, Berndt, SI, Campa, D, Crawford, ED, Diver, WR, Gapstur, SM, Gaziano, JM, Giovannucci, E, Hoover, R, Hunter, DJ, Johansson, M, Kraft, P, Le Marchand, L, Lindström, S, Navarro, C, Overvad, K, Riboli, E, Siddiq, A, Stevens, VL, Trichopoulos, D, Vineis, P, Yeager, M, Trynka, G, Raychaudhuri, S, Schumacher, FR, Price, AL, Freedman, ML, Haiman, CA, Pasaniuc, B

Body mass index and breast cancer survival: a Mendelian randomization analysis by Guo, Q, Burgess, S, Turman, C, Bolla, MK, Wang, Q, Lush, M, Abraham, J, Aittomäki, K, Andrulis, IL, Apicella, C, Arndt, V, Barrdahl, M, Benitez, J, Berg, CD, Blomqvist, C, Bojesen, SE, Bonanni, B, Brand, JS, Brenner, H, Broeks, A, Burwinkel, B, Caldas, C, Campa, D, Canzian, F, Chang-Claude, J, Chanock, SJ, Chin, S-F, Couch, FJ, Cox, A, Cross, SS, Cybulski, C, Czene, K, Darabi, H, Devilee, P, Diver, WR, Dunning, AM, Earl, HM, Eccles, DM, Ekici, AB, Eriksson, M, Evans, DG, Fasching, PA, Figueroa, J, Flesch-Janys, D, Flyger, H, Gapstur, SM, Gaudet, MM, Giles, GG, Glendon, G, Grip, M, Gronwald, J, Haeberle, L, Haiman, CA, Hall, P, Hamann, U, Hankinson, S, Hartikainen, JM, Hein, A, Hiller, L, Hogervorst, FB, Holleczek, B, Hooning, MJ, Hoover, RN, Humphreys, K, Hunter, DJ, Hüsing, A, Jakubowska, A, Jukkola-Vuorinen, A, Kaaks, R, Kabisch, M, Kataja, V, Kconfab/Aocs Investigators, Knight, JA, Koppert, LB, Kosma, V-M, Kristensen, VN, Lambrechts, D, Le Marchand, L, Li, J, Lindblom, A, Lindström, S, Lissowska, J, Lubinski, J, Machiela, MJ, Mannermaa, A, Manoukian, S, Margolin, S, Marme, F, Martens, JWM, McLean, C, Menéndez, P, Milne, RL, Mulligan, A, Muranen, TA, Nevanlinna, H, Neven, P, Nielsen, SF, Nordestgaard, BG, Olson, JE, Perez, JIA, Peterlongo, P, Phillips, K-A, Poole, CJ, Pylkäs, K, Radice, P, Rahman, N, Rüdiger, T, Rudolph, A, Sawyer, EJ, Schumacher, F, Seibold, P, Seynaeve, C, Shah, M, Smeets, A, Southey, MC, Tollenaar, RAEM, Tomlinson, I, Tsimiklis, H, Ulmer, H-U, Vachon, C, Van Den Ouweland, AMW, Veer, LJ, Wildiers, H, Willett, W, Winqvist, R, Zamora, MP, Chenevix-Trench, G, Dörk, T, Easton, DF, García-Closas, M, Kraft, P, Hopper, JL, Zheng, W, Schmidt, MK, Pharoah, PDP

Interim results from the IMPACT study: evidence for prostate-specific antigen screening in BRCA2 mutation carriers by Page, EC, Bancroft, EK, Brook, MN, Assel, M, Battat, M, Thomas, S, Taylor, N, Chamberlain, A, Pope, J, Raghallaigh, HN, Evans, DG, Rothwell, J, Mahle, L, Grindedal, EMM, James, P, Mascarenhas, L, McKinley, J, Side, L, Thomas, T, Van Asperen, C, Vasen, H, Kiemeney, LA, Ringelberg, J, Jensen, TD, Osther, PJS, Helfand, BT, Genova, E, Oldenburg, RA, Cybulski, C, Wokolorczyk, D, Ong, K-R, Huber, C, Lam, J, Taylor, L, Salinas, M, Feliubadaló, L, Oosterwijk, JC, Van Zelst-Stams, W, Cook, J, Rosario, DJ, Domchek, S, Powers, J, Buys, S, O'Toole, K, Ausems, MGEM, Schmutzler, RK, Rhiem, K, Izatt, L, Tripathi, V, Teixeira, MR, Cardoso, M, Foulkes, WD, Aprikian, A, Van Randeraad, H, Davidson, R, Longmuir, M, Ruijs, MWG, Van Den Enden, ATJM, Adank, M, Williams, R, Andrews, L, Murphy, DG, Halliday, D, Walker, L, Liljegren, A, Carlsson, S, Azzabi, A, Jobson, I, Morton, C, Shackleton, K, Snape, K, Hanson, H, Harris, M, Tischkowitz, M, Taylor, A, Kirk, J, Susman, R, Chen-Shtoyerman, R, Spigelman, A, Pachter, N, Ahmed, M, Cajal, T, Zgajnar, J, Brewer, C, Gadea, N, Brady, AF, Van Os, T, Gallagher, D, Johannsson, O, Donaldson, A, Barwell, J, Nicolai, N, Friedman, E, Obeid, E, Greenhalgh, L, Murthy, V, Copakova, L, Saya, S, McGrath, J, Cooke, P, Rønlund, K, Richardson, K, Henderson, A, Teo, SH, Arun, B, Kast, K, Dias, A, Aaronson, NK, Ardern-Jones, A, Bangma, CH, Castro, E, Dearnaley, D, Eccles, DM, Tricker, K, Eyfjord, J, Falconer, A, Foster, C, Gronberg, H, Hamdy, FC, Stefansdottir, V, Khoo, V, Lindeman, GJ, Lubinski, J, Axcrona, K, Mikropoulos, C, Mitra, A, Moynihan, C, Rennert, G, Suri, M, Wilson, P, Dudderidge, T, Impact Study Collaborators, Offman, J, Kote-Jarai, Z, Vickers, A, Lilja, H, Eeles, RA